Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Hyperekplexia, microcephaly and simplified gyral pattern caused by novel ASNS mutations, case report

  • Mohammed Zain Seidahmed1Email author,
  • Mustafa A. Salih2,
  • Omer B. Abdulbasit1,
  • Abdulmohsen Samadi1,
  • Khalid Al Hussien1,
  • Abeer M. Miqdad1,
  • Maha S. Biary3,
  • Anas M. Alazami4,
  • Ibrahim A. Alorainy5,
  • Mohammad M. Kabiraj6,
  • Ranad Shaheen4 and
  • Fowzan S. Alkuraya4, 7
Contributed equally
BMC NeurologyBMC series – open, inclusive and trusted201616:105

https://doi.org/10.1186/s12883-016-0633-0

Received: 16 October 2015

Accepted: 7 July 2016

Published: 15 July 2016

Abstract

Background

Asparagine synthetase deficiency (OMIM# 615574) is a very rare newly described neurometabolic disorder characterized by congenital microcephaly and severe global developmental delay, associated with intractable seizures or hyperekplexia. Brain MRI typically shows cerebral atrophy with simplified gyral pattern and delayed myelination. Only 12 cases have been described to date. The disease is caused by homozygous or compound heterozygous mutations in the ASNS gene on chromosome 7q21.

Case presentation

Family 1 is a multiplex consanguineous family with five affected members, while Family 2 is simplex. One affected from each family was available for detailed phenotyping. Both patients (Patients 1 and 2) presented at birth with microcephaly and severe hyperekplexia, and were found to have gross brain malformation characterized by simplified gyral pattern, and hypoplastic cerebellum and pons. EEG showed no epileptiform discharge in Patient 2 but multifocal discharges in patient 1. Patient 2 is currently four years old with severe neurodevelopmental delay, quadriplegia and cortical blindness. Whole exome sequencing (WES) revealed a novel homozygous mutation in ASNS (NM_001178076.1) in each patient (c.970C > T:p.(Arg324*) and c.944A > G:p.(Tyr315Cys)).

Conclusion

Our results expand the mutational spectrum of the recently described asparagine synthetase deficiency and show a remarkable clinical homogeneity among affected individuals, which should facilitate its recognition and molecular confirmation for pertinent and timely genetic counseling.

Keywords

Hyperekplexia Brain malformation Asparagine synthetase deficiency ASNS gene Whole exome sequencing Arthrogryposis Case report

Background

Asparagine synthetase deficiency (ASNSD, OMIM# 615574) is a very rare newly described autosomal recessive neurometabolic disorder, caused by homozygous or compound heterozygous mutations in the ASNS gene on chromosome 7q21 [1]. The phenotype is characterized by microcephaly, severely delayed psychomotor development, progressive encephalopathy, cortical atrophy with reduced cerebral volume and enlarged lateral ventricles (associated in some with cerebellar and pontine hypoplasia, simplified gyral pattern, cortical dysgenesis and delayed myelination), intractable seizures or hyperekplexic activity, appendicular hypertonia and hyperreflexia [1]. Other associated features include micrognathia, receding forehead, relatively large ears, axial hypotonia and cortical blindness.

To the best of our knowledge, only 12 patients were described in the literature including the nine original patients reported by Ruzzo et al. [1] from four families of Iranian Jewish, French Canadian, and Bangladeshi origins, two of whom were consanguineous. Two patients were subsequently reported by Alfadhel et al. [2] from Saudi Arabia, and another reported by Ben-Salem et al. [3] from United Arab Emirates, all born to consanguineous parents (Table 1).
Table 1

Clinical features of cases with asparagine synthetase deficiency due to ASNS gene mutation

 

Present report

Ruzzo et al. [1]

Ben Salem et al. [3]

Alfadhel et al. [2]

 

Patient 1

Patient 2

Number of pts

2

 

9

1

2

Number of families

2

 

4

1

1

Age

1 month

4 Yrs

9 month–14 Yrs

5 Yrs

2 Yrs/4 Yrs

Gender

M

M

8M/1F

M

1M/1F

Ethnic origin

Arab

Arab

Iranian Jews, French

Arab

Arab

Canadian, Bangladeshi

Consanguinity

Yes

Yes

Yes in two families

Yes

Yes

Mutation in ASNS gene

c.1219C > T

c.944A > G

c. 1084T > G(p.Phe 362Val

c. 1193 A > C p.Y 398 C

c. 1160A > G

p.(Arg407)

p.Y 315 C

c. 1648C > T(p.Arg 550Cys

p. Tyr 377Cys

c 17C > A(p. A6E

Type of mutation

Nonsense homozygous

Missense, homozygous

Missense, homozygous, compound heterozygous

Missense, homozygous

Missense, homozygous

Developmental delay

 

Severe

Severe

Severe

Severe

Head circumference (cm )at birth

29

29

28.5–33

29.5

30 and 26.5

Hypertonia

No

Yes

Yes

Yes

Yes

Spastic quadriplegia

No

Yes

Yes

Yes

Yes

Seizure

Yes

No

6 patients

Yes

Yes, both

Hyperekplexia

Yes

Yes

Three patients

No

No

EEG Pattern

Epileptic encephalopathy in a transitional phase with predominant SZ burdens

Low amplitude bilaterally but no clear epileptiform discharge

• Disorganized background In hyperekplexia cases

• Hypsarrhythmia

• Suppression burst

Abnormal background activity bilaterally, low amplitude and frequent interictal multifocal spike

Multiple independent spike foci

MRI Brain

Microcephaly, smooth thin cerebral cortex, simplified gyral pattern, global brain atrophy, delayed myelination, hypoplastic cerebellum and pons

Microcephaly, smooth thin cerebral cortex, simplified gyral pattern, global brain atrophy, delayed myelination, hypoplastic cerebellum and pons

All have severe microcephaly, brain atrophy delayed myelination, decreased size of the pons and simplified gyral pattern

Severe microcephaly thin corpus callosum, ventriculomegaly, brain atrophy, decreased size of pons, simplified gyral pattern

Both severe microcephaly brain atrophy, delayed myelination and simplified gyral pattern

Abbreviations: M male, F female, Yrs years, EEG electroencephalography, MRI magnetic resonance image

In this report, we describe two additional cases from Saudi Arabia belonging to two consanguineous families, with typical clinical and radiological features of ASNSD. The diagnosis was confirmed by whole exome sequencing (WES), which revealed two novel mutations in the ASNS gene. This is the fourth ASNSD report in the literature.

Case presentation

Patient 1

The proband (Fig. 1, V: 2) is 1-month-old Saudi boy born normally at term to first 24-year- old parents. Four maternal aunts (Fig. 1, IV: 1, 4, 7, 8.) had died at the age of four, five, three and six weeks respectively, in a remote medical facility with no available records. However, all are said to have presented with microcephaly and abnormal movements similar to the index (see below). The mother was G2P1 (IUFD at 28 weeks gestation) +0. No history of exposures. Antenatal ultrasound (US) scan showed microcephaly. Apgar score was 9 and 10 at one and five minutes, respectively. Birth weight 2675gm (10th percentile), head circumference 29 cm (−3SD). Examination showed microcephaly, sloping forehead, short neck, and micrognathia (Fig. 2a). Shortly after birth, he developed abnormal movements in the form of bursts of tonic/clonic movements provoked by non-habituating glabellar and root of the nose tapping, sound and light (see Additional files 1, 2 and 3). There was hyperreflexia, hypertonia and arthrogryposis of the lower limbs. He developed frequent apneas necessitating mechanical ventilation. Treatment with clonazepam was initiated and later phenobarbitone was added to control the abnormal movements. Laboratory investigations (Table 2) showed normal metabolic screen including plasma and CSF asparagine, glutamine, aspartate and glutamate.CSF neurotransmitters, 5HIAA, 3-OMD, and HVA were normal. Brain MRI (Fig. 3) revealed cerebral atrophy, simplified gyral pattern and hypoplastic cerebellum and pons. EEG showed multifocal discharges, fast spiking in the left hemisphere favoring cortical dysplasia, and frontal spikes. The findings favor epileptic encephalopathy in a transitional phase with predominant seizure burdens. Whole exome sequence (WES) revealed nonsense mutation in the ASNS gene, (NM_001178076.1: c.970C > T p. (Arg324*). He died at the age of six weeks in status epilepticus.
Fig. 1

Pedigrees of the two study families. The sequence chromatograms of the mutant alleles are shown below the respective pedigrees

Fig. 2

a Photograph of patient 1 showing microcephaly, slopingforehead, micrognathia, and relatively large ears. b Photograph of patient 2 at age of four years. Note microcephaly, relatively large ears, sloping forehead, and severe contractures of all limbs (spastic quadriplegic posture)

Table 2

Biochemical findings in patient 1

Test

Plasma

Reference range

Cerebrospinal fluid

Reference range

Asparagine (μ mol/L)

55

25–91

5

0–12

Glutamine (μ mol/L)

834

316–1020

639

232–725

Glutamic acid (μ mol/L)

125

31–202

2

0–27

Aspartic acid (μ mol/L)

33

2–20

<1

0–3

CSF Neurotransmitters

 5-hydoxyindoleacetic acid(5HIAA) (n mol/L)

281

Newborn (208–1159)

 Homovanillic acid (HVA) (n mol/L)

410

Newborn (337–1299)

 3-O-methyldopa (3-OMD) (n mol/L)

79

Newborn (0–300)

 Urine organic acid

Normal

Fig. 3

Brain MR images at day 1 after birth of patient 1. a Sagittal T1-weighted image showing severe microcephaly, simplified gyral pattern, thin corpus callosum, small cerebellum, and small pons. b Axial T1-weighted image demonstrating small pons and cerebellum. c Axial T1-weighted image showing delayed myelination of the posterior limb of internal capsule, bilaterally. d Coronal FLAIR image demonstrating severely simplified gyral pattern and large extra-axial CSF spaces reflecting brain underdevelopment. e Proton MR Spectroscopy with long TE showing normal spectra for age

Patient 2

Is a 4- year-old Saudi boy delivered normally at term to a 23-year-old primigravida lady and her 25-year-old first cousin husband (Fig. 1, IV:1). Antenatal US scan revealed microcephaly but pregnancy was uneventful otherwise. Apgar score was 9 and 10 at one and five minutes, respectively. Birth weight 2790 gm (25th percentile), length 51 cm (50th percentile) and head circumference 30 cm (−2.6SD). He was admitted to the Neonatal Intensive Care Unit (NICU) because of microcephaly and abnormal movements. Clinical examination showed microcephaly, staring anxious look, sloping forehead, receding chin and relatively large ears. Neurological examination revealed tonic/clonic rapid movements of both upper and lower limbs, with positive head retraction reflex (HRR). The attacks were provoked by glabellar and tip of the nose tapping, were non-habituating and precipitated by sounds. Additional files 4, 5, and 6 show this in more detail. Hypertonia with exaggerated reflexes and arthrogryposis of both upper and lower limbs were also noted. The rest of the systemic examination revealed no abnormality. He was initially managed by phenobarbitone. Clonazepam and levetiracetam were later added due to the intractable movements. At the age of four years he was found to have profound global developmental delay and spastic quadriplegia with severe contractures of both upper and lower limbs (Fig. 2b). He also had cortical blindness and hyperekplexic activities could still be elicited by glabellar and root of the nose tapping, light and sounds [see Additional files 1, 2, 3, 4, 5 and 6]. His growth parameters were severely retarded: his weight 5.3 Kg (−6.8SD) and head circumference was 35 cm (−10.1SD).

Laboratory tests including hematologic indices, renal function, liver function, and electrolytes were all normal. Metabolic screen, plasma amino acids, lactate, and ammonia were unremarkable. Chromosome study revealed normal male karyotype. MRI brain (Fig. 4) showed microcephaly, thin and smooth cortex with simplified gyral pattern [4], delayed myelination, dilatation of the ventricles, global brain atrophy and hypoplastic cerebellum and pons. EEG showed very low amplitude bilaterally without epileptiform discharges. Only sporadic sharp transient spikes, most likely myogenic in origin, were noted. Genetic testing, utilizing whole exome sequencing (WES), showed a novel homozygous ASNS gene mutation: NM_001178076.1, missense c.944A > G, p. (Tyr315Cys). Both parents are heterozygous carriers. This change was absent in 615 in-house Saudi exomes, and is predicted pathogenic by PolyPhen (0.992), SIFT (1.0) and CADD (28.7) [5]. The family was offered genetic counselling.
Fig. 4

MRI brain at the age of 3 weeks. a Sagittal T1-weighted image showing severe microcephaly with overlapped lambdoid sutures, brain underdevelopment evident by simplified gyral pattern, small cerebellum, and small pons. b Axial FLAIR image revealing small pons and cerebellum. c Axial T1-weighted image demonstrating delayed myelination evident by absent myelination of the posterior limb of internal capsule, bilaterally. d Coronal T2-weighted image showing simplified gyral pattern (more in the frontal lobes) and large extra-axial CSF spaces due to brain underdevelopment

We report two novel mutations in the ASNS gene in two Saudi patients from first cousin marriages who presented with congenital microcephaly, hyperekplexia, cerebral atrophy, simplified gyral pattern, and hypoplastic cerebellum and pons (Figs. 3 and 4). The phenotype is consistent with the recently described ASNSD (OMIM# 615574). ASNS encodes an asparagine synthetase enzyme involved in the synthesis of asparagine from glutamine and aspartate [6]. The neurological impairment resulting from ASNS mutation can be explained by asparagine depletion in the brain or by accumulation of aspartate /glutamate leading to enhanced excitation and neuronal damage [1]. To date five pathogenic mutations in the ASNS gene have been identified (Table 1).

All cases of asparagine synthetase deficiency were diagnosed by molecular genetics as there is no reliable biochemical test for diagnosing the disorder. Alfadhel et al. [2] reported low levels of asparagine in the CSF of two siblings with ASNSD confirmed by molecular genetics, while Ruzzo et al. [1] reported low asparagine levels in the CSF of only two of the five patients with the disorder. Our two patients had normal plasma and CSF asparagine, glutamine, aspartate, and glutamate and CSF neurotransmitters (Table 2). Therefore, this condition cannot be ruled out by normal plasma and CSF asparagine, aspartate and glutamate levels (Table 3) in a patient presenting with congenital microcephaly, and unexplained encephalopathy in the form of intractable seizures or hyperekplexia [1].
Table 3

Biochemical Findings in ASNSD

 

Plasma

Cerebrospinal fluid (CSF)

 
 

Asparagine μmol/L

Glutamine μmol /L

Aspartate μmol /L

Glutamate μmol /L

Asparagine μmol /L

Glutamine μmol /L

Aspartate μmol /L

Glutamate μmol /L

Comment

A. Present Report (2015)

 Patient 1

55 (25–91)

834 (316–1020)

33 (2–20)

125 (31–202)

5 (0–12)

639 (232–725)

<1 (0–3)

2 (0–27)

Slightly Elevated Plasma Aspartate

 Patient 2

Normal

Normal

Normal

Normal

N/A

N/A

N/A

N/A

 

B. Majid Alfadhel et. al (2014) [2]

 Patient 1

10 (33–68.4)

339 (254–823)

N/A

N/A

Not detected (1.1–6.9)

922 (356–680)

N/A

N/A

Low Plasma and CSF Asparagine

 Patient 2

6 (33–68.4)

328 (254–823)

N/A

N/A

1 (1.1–6.9)

574 (356–680)

N/A

N/A

Low Plasma and CSF Asparagine

C. Ruzzo el. al (2013) [1]

 1

57 (23–112)

1250 (254–823)

18 (1–24)

N/A

N/A

N/A

N/A

N/A

High Plasma Glutamate

 2

49 (23–112)

1149 (254–823)

2 (1–24)

N/A

N/A

N/A

N/A

N/A

High Plasma Glutamate

 3

N/A

N/A

7 (17–21)

N/A

N/A

N/A

N/A

N/A

Low Plasma Aspartate

 4

12 (16–21)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Low Plasma Asparagine

 5

N/A

N/A

12 (0–20)

N/A

N/A

N/A

N/A

N/A

 

 6

11 (31–56)

439 (474–736)

7 (4–18)

N/A

N/A

N/A

N/A

N/A

Low Plasma Asparagine

 7

55 (31–56)

668 (474–736)

9 (4–18)

N/A

N/A

N/A

N/A

N/A

 

Ben-Salem et. al (2015)

Normal

Normal

Normal

Normal

N/A

N/A

N/A

N/A

 

Legend: N/A Not Available

ASNSD is a very rare disorder with a prevalence of <1/1000000 worldwide (ORPHA 391376); and hitherto, only 12 cases have been reported. We suspect this condition is underdiagnosed due to lack of recognition and the risk of confusing the hyperekplexia phenotype for nonspecific neonatal epilepsy, and also due to lack of a specific laboratory test and the difficulty of performing molecular genetic testing in suspected cases except in research centers or referral hospitals. Given that there is no reliable biochemical test, sequencing of ASNS is the mainstay of diagnosis. While our two patients were diagnosed using WES, this gene can easily be targeted by Sanger sequencing or added to a gene panel approach as described before [7]. The clinical and radiographic presentation of our patients, namely congenital microcephaly, hyperekplexia, brain malformation, and (in long term survivors) severe psychomotor retardation and cortical blindness is identical to that observed in the patients reported by Ruzzo et al. [1] with ASNS gene mutation. Interestingly, we previously [8] reported six patients with a similar presentation of hyperekplexia, microcephaly and brain malformations who later proved to have cathepsin deficiency (CTSD) known to be associated with congenital ceroid lipofuscinosis neuronal 10 (CLN 10) [9, 10]. Our observation raises the intriguing possibility of a link between asparagine synthetase deficiency and cathepsin deficiency, although this will require future research. Both disorders should be considered in microcephalic neonates who present with seizures or hyperekplexia at or before birth, and molecular genetic testing needs to be performed for pertinent and timely genetic counseling. This will pave the way for adopting effective preventive and therapeutic approaches like preimplantation genetic diagnosis (PGD), or early termination of affected pregnancies, which helped many families in this region with high prevalence of autosomal recessive disorders [11]. Therapeutic approach by supplementation with asparagine in ASNSD seems attractive. However, the prenatal onset of the microcephaly and early postnatal presentation make such treatment unlikely to be curative unless started prenatally [1].

Conclusion

we expand the allelic heterogeneity of ASNSD and emphasize the clinical homogeneity of this disorder. The remarkable clinical overlap with CTSD-related CLN10 makes it difficult to segregate the two disorders clinically and highlights the need for ANSN and CTSD sequencing to make an accurate diagnosis.

Abbreviations

3-OMD, 3-O-Methyldopa; 5HIAA, 5 hydroxy indole acetic acid; ASNS, asparagine synthetase; ASNSD, asparagine synthetase deficiency; CLN, ceroid lipofuscinosis neuronal; CSF, cerebrospinal fluid; CTSD, cathepsin D; EEG, electroencephalogram; HRR, head retraction reflex; HVA, homo vanillic acid; IUFD, intra uterine fetal death; MRI, magnetic resonance image; NICU, neonatal intensive care unit; PGD, preimplantation genetic diagnosis; SD, standard deviation; US, ultrasound; WES, whole exome sequence

Declarations

Acknowledgements

The authors are grateful to the reported family for participation. We thank the Genotyping and Sequencing Core Facilities at KFSHRC for their technical help. We also thank Mais Hashem, Firdous Abdulwahab and Niema Ibrahim, clinical research coordinators, for their help in recruiting the two families. This work was supported by KCAST grant 13-BIO1113-20 (FSA) and King Salman Center for Disability Research (FSA).Thanks are also due to Thamer Aloudah and Vir Salvador for medical illustration.

Funding

M.A.S. was supported by the Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia through the research group project number RGP-VPP-301.

Availability of data and materials

Data supporting our findings in this case report can be found in the Figs. 1, 2, 3 and 4, and Tables 1, 2 and 3 in the manuscript and supplementary materials (Additional files 1, 2, 3, 4, 5 and 6.Videos).

Authors’ contributions

MZS and MAS conceived of the study, and participated in its design and coordination and drafted the manuscript. OBA, AS, K Al H, AMM. And, MSB, participated in management of patients and data analysis. MA, and, RS, carried out the molecular genetic studies. IAA, studied the radiology, MMUK reported the EEG. FSA designed and coordinated the molecular genetic studies and critically reviewed the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Written informed consent was obtained from the guardians of both patients for publication of this study and the accompanying images and videos. A copy of the written consents is available for review by the Editor-in-Chief of BMC Neurology, (Fig. 2a, b, Additional files 1, 2, 3, 4, 5 and 6).

Ethics approval and consent to participate

The families were enrolled in the study,an informed written consent was used to recruit the patients and their relatives (King Faisal Specialist Hospital and research Center [KFSH/RC]IR13 approved research protocol.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Neonatology Unit, Department of Pediatrics, Security Forces Hospital
(2)
Division of Pediatric Neurology, Department of Pediatrics, College of Medicine, King Saud University
(3)
Pediatric Neurology, Department of Pediatrics, Security Forces Hospital
(4)
Developmental Genetics Unit, Department of Genetics, King Faisal Specialist Hospital and Research Center
(5)
Department of Radiology and Diagnostic Imaging, King Khalid University Hospital and College of Medicine, King Saud University
(6)
Division of Clinical Neurophyisoloy, Department of Neuroscience, Prince Sultan Medical City
(7)
Department of Anatomy and Cell Biology, College of Medicine, Al Faisal University

References

  1. Ruzzo EK, Capo-Chichi JM, Ben-Zeev B, Chitayat D, Mao H, Pappas AL, et al. Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy. Neuron. 2013;80:429–41.View ArticlePubMedGoogle Scholar
  2. Alfadhel M, Alrifai MT, Trujillano D, Alshaalan H, AlOthaim A, Al Rasheed S, et al. Asparagine synthetase deficiency :new inborn error of metabolism. JIMD Reports. 2014: doi:10.1007/8904_2014-405.
  3. Ben–Salem S, Gleeson JG, Al-Shamsi AM, Islam B, Hertecant J, Ali BR, Al-Gazali L. Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay. Metab Brain Dis. 2015;30:687–94.View ArticlePubMedGoogle Scholar
  4. Alazami AM, Patel N, Shamseldin HE, Anazi S, Al-dosari MS, Alzahrani F, et al. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. Cell Rep. 2015;10(2):148–61.View ArticlePubMedGoogle Scholar
  5. Adachi Y, Poduri A, Kawaguch A, Yoon G, Salih MA, Yamashita F, et al. Congenital microcephaly with a simplified gyral pattern: associated findings and their significance. Am J Neuroradiol. 2011;6:1123–9.View ArticleGoogle Scholar
  6. Zhang YP, Lambert MA, Cairney AE, Wills D, Ray PN, Andrulis IL. Molecular structure of the human asparagine synthetase gene. Genomics. 1989;4:259–65.View ArticlePubMedGoogle Scholar
  7. Shamseldin HE, Tulbah M, Kurdi W, Nemer M, Alsahan N, Al Mardawi E, et al. Identification of embryonic lethal genes in humans by autozygosity mapping and exome sequencing in consanguineous families. Genome Biol. 2015;16:116.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Seidahmed MZ, Salih MA, Abdulbasit OB, Shaheed M, Al Hussein K, Miqdad AM, et al. A novel syndrome of lethal familial hyperekplexia associated with brain malformation. BMC Neurol. 2012;12:125.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Steinfeld R, Reinhardt K, Schreiber K, Hillebrand M, Kraetzner R, Bruck W, et al. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet. 2006;78:988–98.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain. 2006;129:1438–45.View ArticlePubMedGoogle Scholar
  11. Al-Gazali L, Ali BR. Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE). Hum Mutat. 2010;31:505–20.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement